Ms Laura Ann Moore, | |
1001 67th Ave Ne, Fridley, MN 55432-4579 | |
(763) 571-9316 | |
Not Available |
Full Name | Ms Laura Ann Moore |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1001 67th Ave Ne, Fridley, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053536201 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 7748 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Laura Ann Moore, 1001 67th Ave Ne, Fridley, MN 55432-4579 Ph: (763) 571-9316 | Ms Laura Ann Moore, 1001 67th Ave Ne, Fridley, MN 55432-4579 Ph: (763) 571-9316 |
News Archive
As the House vote on repealing the health law looms in the near future, some Democrats are contemplating their votes in the context of stiff election pressure or expressing their doubts about the measure's individual mandate. Meanwhile, in a strategic measure, other Democrats are pursuing amendments to the GOP repeal bill that would force up-or-down votes on the health care law's popular consumer provisions.
"In a rare display of bipartisanship,… Rep. Henry Waxman (D-Calif.), chairman of the House Energy and Commerce Committee, said he'd help Dr. Michael Burgess (R-Texas) seek information on the names of representatives from the pharmaceutical, device, hospital, doctor, and insurance sectors, who met with White House officials regarding healthcare reform," Medpage Today/ABC News reports.
Scientists at St. Jude Children's Research Hospital have discovered a new way that the molecule RIPK1 leads to cell death in infected, damaged or unwanted cells showing that more than one mechanism can trigger the process.
BioInvent International AB (publ) (OMXS:BINV) today announced that the company has sold back all its rights to drug development candidate ADC-1013 to former partner Alligator Bioscience for an undisclosed sum.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
› Verified 6 days ago
Elizabeth Marilyn Thompson, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7241 University Ave Ne, Fridley, MN 55432 Phone: 763-450-9400 | |
Kate Patek, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7241 University Ave Ne, Fridley, MN 55432 Phone: 763-450-9400 | |
Brittany J Lahr, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5301 E River Rd Ste 110, Fridley, MN 55421 Phone: 763-432-3926 Fax: 763-432-3926 | |
Cheryl Lemer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 550 Osborne Rd Ne, Mail Route 52680, Fridley, MN 55432 Phone: 763-236-3067 | |
Krystal Nelson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7241 University Ave Ne, Fridley, MN 55432 Phone: 763-450-9400 | |
Sarah Hetz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7241 University Ave Ne, Fridley, MN 55432 Phone: 763-450-9400 |